Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Radiation Therapy
1.2.3 Chemotherapy
1.2.4 Targeted Therapies
1.2.5 Immunotherapy
1.3 Market by Application
1.3.1 Global Lung Cancer Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Therapy Market Perspective (2018-2033)
2.2 Lung Cancer Therapy Growth Trends by Region
2.2.1 Global Lung Cancer Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Lung Cancer Therapy Historic Market Size by Region (2018-2023)
2.2.3 Lung Cancer Therapy Forecasted Market Size by Region (2024-2033)
2.3 Lung Cancer Therapy Market Dynamics
2.3.1 Lung Cancer Therapy Industry Trends
2.3.2 Lung Cancer Therapy Market Drivers
2.3.3 Lung Cancer Therapy Market Challenges
2.3.4 Lung Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Therapy Players by Revenue
3.1.1 Global Top Lung Cancer Therapy Players by Revenue (2018-2023)
3.1.2 Global Lung Cancer Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Lung Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Therapy Revenue
3.4 Global Lung Cancer Therapy Market Concentration Ratio
3.4.1 Global Lung Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Therapy Revenue in 2022
3.5 Lung Cancer Therapy Key Players Head office and Area Served
3.6 Key Players Lung Cancer Therapy Product Solution and Service
3.7 Date of Enter into Lung Cancer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Therapy Breakdown Data by Type
4.1 Global Lung Cancer Therapy Historic Market Size by Type (2018-2023)
4.2 Global Lung Cancer Therapy Forecasted Market Size by Type (2024-2033)
5 Lung Cancer Therapy Breakdown Data by Application
5.1 Global Lung Cancer Therapy Historic Market Size by Application (2018-2023)
5.2 Global Lung Cancer Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Lung Cancer Therapy Market Size (2018-2033)
6.2 North America Lung Cancer Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Lung Cancer Therapy Market Size by Country (2018-2023)
6.4 North America Lung Cancer Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lung Cancer Therapy Market Size (2018-2033)
7.2 Europe Lung Cancer Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Lung Cancer Therapy Market Size by Country (2018-2023)
7.4 Europe Lung Cancer Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Therapy Market Size (2018-2033)
8.2 Asia-Pacific Lung Cancer Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Lung Cancer Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Lung Cancer Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lung Cancer Therapy Market Size (2018-2033)
9.2 Latin America Lung Cancer Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Lung Cancer Therapy Market Size by Country (2018-2023)
9.4 Latin America Lung Cancer Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Therapy Market Size (2018-2033)
10.2 Middle East & Africa Lung Cancer Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Lung Cancer Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Lung Cancer Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Lung Cancer Therapy Introduction
11.1.4 GlaxoSmithKline Revenue in Lung Cancer Therapy Business (2018-2023)
11.1.5 GlaxoSmithKline Recent Development
11.2 Menarini
11.2.1 Menarini Company Detail
11.2.2 Menarini Business Overview
11.2.3 Menarini Lung Cancer Therapy Introduction
11.2.4 Menarini Revenue in Lung Cancer Therapy Business (2018-2023)
11.2.5 Menarini Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Lung Cancer Therapy Introduction
11.3.4 Pfizer Revenue in Lung Cancer Therapy Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Lung Cancer Therapy Introduction
11.4.4 Roche Revenue in Lung Cancer Therapy Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Lung Cancer Therapy Introduction
11.5.4 Merck Revenue in Lung Cancer Therapy Business (2018-2023)
11.5.5 Merck Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Lung Cancer Therapy Introduction
11.6.4 AstraZeneca Revenue in Lung Cancer Therapy Business (2018-2023)
11.6.5 AstraZeneca Recent Development
11.7 Sanofi-Aventis
11.7.1 Sanofi-Aventis Company Detail
11.7.2 Sanofi-Aventis Business Overview
11.7.3 Sanofi-Aventis Lung Cancer Therapy Introduction
11.7.4 Sanofi-Aventis Revenue in Lung Cancer Therapy Business (2018-2023)
11.7.5 Sanofi-Aventis Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Detail
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Lung Cancer Therapy Introduction
11.8.4 Eli Lilly and Company Revenue in Lung Cancer Therapy Business (2018-2023)
11.8.5 Eli Lilly and Company Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Lung Cancer Therapy Introduction
11.9.4 Abbott Revenue in Lung Cancer Therapy Business (2018-2023)
11.9.5 Abbott Recent Development
11.10 Akebia Therapeutics
11.10.1 Akebia Therapeutics Company Detail
11.10.2 Akebia Therapeutics Business Overview
11.10.3 Akebia Therapeutics Lung Cancer Therapy Introduction
11.10.4 Akebia Therapeutics Revenue in Lung Cancer Therapy Business (2018-2023)
11.10.5 Akebia Therapeutics Recent Development
11.11 Agennix AG
11.11.1 Agennix AG Company Detail
11.11.2 Agennix AG Business Overview
11.11.3 Agennix AG Lung Cancer Therapy Introduction
11.11.4 Agennix AG Revenue in Lung Cancer Therapy Business (2018-2023)
11.11.5 Agennix AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Lung Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Radiation Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Targeted Therapies
Table 5. Key Players of Immunotherapy
Table 6. Global Lung Cancer Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Lung Cancer Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Lung Cancer Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Lung Cancer Therapy Market Share by Region (2018-2023)
Table 10. Global Lung Cancer Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Lung Cancer Therapy Market Share by Region (2024-2033)
Table 12. Lung Cancer Therapy Market Trends
Table 13. Lung Cancer Therapy Market Drivers
Table 14. Lung Cancer Therapy Market Challenges
Table 15. Lung Cancer Therapy Market Restraints
Table 16. Global Lung Cancer Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Lung Cancer Therapy Market Share by Players (2018-2023)
Table 18. Global Top Lung Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Therapy as of 2022)
Table 19. Ranking of Global Top Lung Cancer Therapy Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Lung Cancer Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Lung Cancer Therapy Product Solution and Service
Table 23. Date of Enter into Lung Cancer Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lung Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Lung Cancer Therapy Revenue Market Share by Type (2018-2023)
Table 27. Global Lung Cancer Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Lung Cancer Therapy Revenue Market Share by Type (2024-2033)
Table 29. Global Lung Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Lung Cancer Therapy Revenue Market Share by Application (2018-2023)
Table 31. Global Lung Cancer Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Lung Cancer Therapy Revenue Market Share by Application (2024-2033)
Table 33. North America Lung Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Lung Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Lung Cancer Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Lung Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Lung Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Lung Cancer Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Lung Cancer Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Lung Cancer Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Lung Cancer Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Lung Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Lung Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Lung Cancer Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Lung Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Lung Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Lung Cancer Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 48. GlaxoSmithKline Company Detail
Table 49. GlaxoSmithKline Business Overview
Table 50. GlaxoSmithKline Lung Cancer Therapy Product
Table 51. GlaxoSmithKline Revenue in Lung Cancer Therapy Business (2018-2023) & (US$ Million)
Table 52. GlaxoSmithKline Recent Development
Table 53. Menarini Company Detail
Table 54. Menarini Business Overview
Table 55. Menarini Lung Cancer Therapy Product
Table 56. Menarini Revenue in Lung Cancer Therapy Business (2018-2023) & (US$ Million)
Table 57. Menarini Recent Development
Table 58. Pfizer Company Detail
Table 59. Pfizer Business Overview
Table 60. Pfizer Lung Cancer Therapy Product
Table 61. Pfizer Revenue in Lung Cancer Therapy Business (2018-2023) & (US$ Million)
Table 62. Pfizer Recent Development
Table 63. Roche Company Detail
Table 64. Roche Business Overview
Table 65. Roche Lung Cancer Therapy Product
Table 66. Roche Revenue in Lung Cancer Therapy Business (2018-2023) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Merck Company Detail
Table 69. Merck Business Overview
Table 70. Merck Lung Cancer Therapy Product
Table 71. Merck Revenue in Lung Cancer Therapy Business (2018-2023) & (US$ Million)
Table 72. Merck Recent Development
Table 73. AstraZeneca Company Detail
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Lung Cancer Therapy Product
Table 76. AstraZeneca Revenue in Lung Cancer Therapy Business (2018-2023) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Sanofi-Aventis Company Detail
Table 79. Sanofi-Aventis Business Overview
Table 80. Sanofi-Aventis Lung Cancer Therapy Product
Table 81. Sanofi-Aventis Revenue in Lung Cancer Therapy Business (2018-2023) & (US$ Million)
Table 82. Sanofi-Aventis Recent Development
Table 83. Eli Lilly and Company Company Detail
Table 84. Eli Lilly and Company Business Overview
Table 85. Eli Lilly and Company Lung Cancer Therapy Product
Table 86. Eli Lilly and Company Revenue in Lung Cancer Therapy Business (2018-2023) & (US$ Million)
Table 87. Eli Lilly and Company Recent Development
Table 88. Abbott Company Detail
Table 89. Abbott Business Overview
Table 90. Abbott Lung Cancer Therapy Product
Table 91. Abbott Revenue in Lung Cancer Therapy Business (2018-2023) & (US$ Million)
Table 92. Abbott Recent Development
Table 93. Akebia Therapeutics Company Detail
Table 94. Akebia Therapeutics Business Overview
Table 95. Akebia Therapeutics Lung Cancer Therapy Product
Table 96. Akebia Therapeutics Revenue in Lung Cancer Therapy Business (2018-2023) & (US$ Million)
Table 97. Akebia Therapeutics Recent Development
Table 98. Agennix AG Company Detail
Table 99. Agennix AG Business Overview
Table 100. Agennix AG Lung Cancer Therapy Product
Table 101. Agennix AG Revenue in Lung Cancer Therapy Business (2018-2023) & (US$ Million)
Table 102. Agennix AG Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Lung Cancer Therapy Market Share by Type: 2022 VS 2033
Figure 3. Radiation Therapy Features
Figure 4. Chemotherapy Features
Figure 5. Targeted Therapies Features
Figure 6. Immunotherapy Features
Figure 7. Global Lung Cancer Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Lung Cancer Therapy Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Other Case Studies
Figure 12. Lung Cancer Therapy Report Years Considered
Figure 13. Global Lung Cancer Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Lung Cancer Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Lung Cancer Therapy Market Share by Region: 2022 VS 2033
Figure 16. Global Lung Cancer Therapy Market Share by Players in 2022
Figure 17. Global Top Lung Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Therapy as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Lung Cancer Therapy Revenue in 2022
Figure 19. North America Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Lung Cancer Therapy Market Share by Country (2018-2033)
Figure 21. United States Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Lung Cancer Therapy Market Share by Country (2018-2033)
Figure 25. Germany Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Lung Cancer Therapy Market Share by Region (2018-2033)
Figure 33. China Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Lung Cancer Therapy Market Share by Country (2018-2033)
Figure 41. Mexico Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Lung Cancer Therapy Market Share by Country (2018-2033)
Figure 45. Turkey Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Lung Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Lung Cancer Therapy Business (2018-2023)
Figure 48. Menarini Revenue Growth Rate in Lung Cancer Therapy Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Lung Cancer Therapy Business (2018-2023)
Figure 50. Roche Revenue Growth Rate in Lung Cancer Therapy Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Lung Cancer Therapy Business (2018-2023)
Figure 52. AstraZeneca Revenue Growth Rate in Lung Cancer Therapy Business (2018-2023)
Figure 53. Sanofi-Aventis Revenue Growth Rate in Lung Cancer Therapy Business (2018-2023)
Figure 54. Eli Lilly and Company Revenue Growth Rate in Lung Cancer Therapy Business (2018-2023)
Figure 55. Abbott Revenue Growth Rate in Lung Cancer Therapy Business (2018-2023)
Figure 56. Akebia Therapeutics Revenue Growth Rate in Lung Cancer Therapy Business (2018-2023)
Figure 57. Agennix AG Revenue Growth Rate in Lung Cancer Therapy Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed